Role of circular RNA in tumor proliferation and metastasis

doi:10.3969/j.issn.1673-8640.2020.08.022

Abstract

CLC Number:

R446.1

HOU Yanyan, FAN Jinong, LIU Xiangfan, NI Peihua. Role of circular RNA in tumor proliferation and metastasis[J]. Laboratory Medicine, 2020, 35(8): 837-842.

Figures/Tables 2

References 36

[1]	PATOP I L,WÜST S,KADENER S. Past,present,and future of circRNAs[J]. EMBO J,2019,38(16):e100836.
[2]	SALZMAN J,GAWAD C,WANG P L,et al. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types[J]. PLoS One,2012,7(2):e30733.
[3]	JECK W R,SORRENTINO J A,WANG K,et al. Circular RNAs are abundant,conserved,and associated with ALU repeats[J]. RNA,2013,19(2):141-157.
[4]	DONG R,MA X K,CHEN L L,et al. Increased complexity of circRNA expression during species evolution[J]. RNA Biol,2017,14(8):1064-1074.
[5]	WEI C Y,ZHU M X,LU N H,et al. Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma[J]. Mol Cancer,2020,19(1):84.
[6]	RYBAK-WOLF A,STOTTMEISTER C,GLAŽAR P,et al. Circular RNAs in the mammalian brain are highly abundant,conserved,and dynamically expressed[J]. Mol Cell,2015,58(5):870-885.
[7]	ZHU Y J,ZHENG B,LUO G J,et al. Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma[J]. Theranostics,2019,9(12):3526-3540.
[8]	CHEN L,KONG R,WU C,et al. Circ-MALAT1 functions as both an mRNA translation brake and a microRNA sponge to promote self-renewal of hepatocellular cancer stem cells[J]. Adv Sci(Weinh),2019,7(4):1900949.
[9]	WANG S,TANG D,WANG W,et al. circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer[J]. Mol Cancer,2019,18(1):162.
[10]	XU G,YE D,ZHAO Q,et al. circNFIC suppresses breast cancer progression by sponging miR-658[J]. J Cancer,2020,11(14):4222-4229.
[11]	DING L,ZHAO Y,DANG S,et al. Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4[J]. Mol Cancer,2019,18(1):45.
[12]	LI T,SHAO Y,FU L,et al. Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection[J]. J Mol Med,2018,96(1):85-96.
[13]	DAHL M,DAUGAARD I,ANDERSEN M S,et al. Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies[J]. Lab Invest,2018,98(12):1657-1669.
[14]	ZHENG F,WANG M,LI Y,et al. CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression[J]. Cancer Lett,2019,460:139-151.
[15]	TIAN F,YU C,WU M,et al. MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR-191/KLF6 axis[J]. Cell Prolif,2019,52(5):e12635.
[16]	BI J,LIU H,DONG W,et al. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence[J]. Mol Cancer,2019,18(1):133.
[17]	XIE F,LI Y,WANG M,et al. Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis[J]. Mol Cancer,2018,17(1):144.
[18]	DU W W,YANG W,LIU E,et al. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2[J]. Nucleic Acids Res,2016,44(6):2846-2858.
[19]	FANG L,DU W W,AWAN F M,et al. The circular RNA circ-Ccnb1 dissociates Ccnb1/Cdk1 complex suppressing cell invasion and tumorigenesis[J]. Cancer Lett,2019,459:216-226.
[20]	CHEN X,CHEN R X,WEI W S,et al. PRMT5 circular RNA promotes metastasis of urothelial carcinoma of the bladder through sponging miR-30c to induce epithelial-mesenchymal transition[J]. Clin Cancer Res,2018,24(24):6319-6330.
[21]	MA H B,YAO Y N,YU J J,et al. Extensive profiling of circular RNAs and the potential regulatory role of circRNA-000284 in cell proliferation and invasion of cervical cancer via sponging miR-506[J]. Am J Transl Res,2018,10(2):592-604.
[22]	LI X,TIAN Y,HU Y,et al. CircNUP214 sponges miR-145 to promote the expression of ZEB2 in thyroid cancer cells[J]. Biochem Biophys Res Commun,2018,507(1-4):168-172.
[23]	MENG J,CHEN S,HAN J X,et al. Twist1 regulates vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma[J]. Cancer Res,2018,78(15):4150-4162.
[24]	HUANG H,WEI L,QIN T,et al. Circular RNA ciRS-7 triggers the migration and invasion of esophageal squamous cell carcinoma via miR-7/KLF4 and NF-κB signals[J]. Cancer Biol Ther,2019,20(1):73-80.
[25]	ZHU Z,RONG Z,LUO Z,et al. Circular RNA circNHSL1 promotes gastric cancer progression through the miR-1306-3p/SIX1/vimentin axis[J]. Mol Cancer,2019,18(1):126.
[26]	YANG Z,QU C B,ZHANG Y,et al. Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway[J]. Oncogene,2019,38(14):2516-2532.
[27]	LI Y,WAN B,LIU L,et al. Circular RNA circMTO1 suppresses bladder cancer metastasis by sponging miR-221 and inhibiting epithelial-to-mesenchymal transition[J]. Biochem Biophys Res Commun,2019,508(4):991-996.
[28]	SU Y,FENG W,SHI J,et al. circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway[J]. Mol Cancer,2020,19(1):23.
[29]	CHEN J,LIU G,WU Y,et al. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling[J]. Mol Cancer,2019,18(1):150.
[30]	XU H,ZHANG Y,QI L,et al. NFIX circular RNA promotes glioma progression by regulating miR-34a-5p via Notch signaling pathway[J]. Front Mol Neurosci,2018,11:225.
[31]	ZHANG X,WANG S,WANG H,et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway[J]. Mol Cancer,2019,18(1):20.
[32]	WANG H,XIAO Y,WU L,et al. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis[J]. Int J Oncol,2018,52(3):743-754.
[33]	WANG W,WANG J,ZHANG X,et al. Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer[J]. Onco Targets Ther,2019,12:7451-7457.
[34]	GAN X,ZHU H,JIANG X,et al. CircMUC16 promotes autophagy of epithelial ovarian cancer via interaction with ATG13 and miR-199a[J]. Mol Cancer,2020,19(1):45.
[35]	HE F,ZHONG X,LIN Z,et al. Plasma exo-hsa_circRNA_0056616:a potential biomarker for lymph node metastasis in lung adenocarcinoma[J]. J Cancer,2020,11(14):4037-4046.
[36]	LIU X,TANG H,LIU J,et al. hsa_circRNA_101237:a novel diagnostic and prognostic biomarker and potential therapeutic target for multiple myeloma[J]. Cancer Manag Res,2020,12:2109-2118.

方法	优点	局限性	参考文献
circRNA测序	有助于发现有潜力的circRNA分子	检测结果可能包括对RNase R有抗性的线性 RNA	[9]
微阵列	需要较少的生物信息学知识,是 RNA-seq可行的替代方法	只能分析有限数量的已知circRNA,,并且不能提供对应的线性对应物的信息	[10]
Northern印迹分析	可用于评估circRNA的大小、同工型、序列和丰度	操作复杂,不能用于高通量检测	[11]
实时定量PCR	实验条件简单,并且可以验证 circRNA的完整序列	存在滚环效应影响检测的精确度	[5]
数字液滴PCR	可量化circRNA拷贝数	需要专用设备和试剂	[12]
NanoString nCounter荧光条形码标记单分子检测技术	有一定的检测通量且能绝对定量	需要专用设备和试剂	[13]

方法	优点	局限性	参考文献
circRNA测序	有助于发现有潜力的circRNA分子	检测结果可能包括对RNase R有抗性的线性 RNA	[9]
微阵列	需要较少的生物信息学知识,是 RNA-seq可行的替代方法	只能分析有限数量的已知circRNA,,并且不能提供对应的线性对应物的信息	[10]
Northern印迹分析	可用于评估circRNA的大小、同工型、序列和丰度	操作复杂,不能用于高通量检测	[11]
实时定量PCR	实验条件简单,并且可以验证 circRNA的完整序列	存在滚环效应影响检测的精确度	[5]
数字液滴PCR	可量化circRNA拷贝数	需要专用设备和试剂	[12]
NanoString nCounter荧光条形码标记单分子检测技术	有一定的检测通量且能绝对定量	需要专用设备和试剂	[13]

相关蛋白/通路	circRNA	失调情况	靶标miRNA	靶标蛋白	肿瘤	参考文献
细胞周期相关蛋白/激酶
cyclin	circNR3C1	下调	miR-27a-3p	cyclin D1	膀胱癌	[14]
	has_circ_0000204	下调	miR-191	KLF6	肝癌	[15]
CKI	circ-ZKSCAN1	下调	miR-1178-3p	P21	膀胱癌	[16]
	circRNA BCRC-3	下调	miR-182-5p	P27	膀胱癌	[17]
CDK	circ-Foxo3	上调	-	P21/CDK2	乳腺癌	[18]
	circ-Ccnb1	下调	-	cyclin B1/CDK1	乳腺癌	[19]
EMT相关蛋白
EMT-TF	circPRMT5	上调	miR-30c	Snail	尿道上皮癌	[20,21]
	circNUP214	上调	miR-145	ZEB2	甲状腺乳头状癌	[22]
	circ-10720	上调	miR-490-5p	Twist1	肝细胞癌	[23]
	cirs-7	上调	miR-7	KLF4	食管鳞状细胞癌	[24]
	circNHSL1	上调	miR-1306-3p	Vimentin	胃癌	[25]
细胞黏附分子与骨架蛋白	circAMOTL1L	下调	miR-193a-5p	Pcdha8	前列腺癌	[25]
	circMTO1	上调	miR-221	N-CAD	膀胱癌	[26]
	circPTK2	下调	miR-429/miR-200b-3p	TIF1γ	非小细胞肺癌	[34]
相关信号通路
TGF-β/Smad	circRIP2	上调	miR-1305	TGF-β2	膀胱癌	[28]
Wnt/β-catenin	circMYO10	上调	miR-370-3p	RUVBL1	骨肉瘤	[29]
Notch	circNFIX	上调	miR-34a-5p	Notch1	神经胶质瘤	[30]
PI3K/Akt/mTOR	circNRIP1	上调	miR-149-5p	AKT1 / mTOR	胃癌	[31]
NF-κB	circRNA-000911	上调	miR-449a	Notch1	乳腺癌	[32]

相关蛋白/通路	circRNA	失调情况	靶标miRNA	靶标蛋白	肿瘤	参考文献
细胞周期相关蛋白/激酶
cyclin	circNR3C1	下调	miR-27a-3p	cyclin D1	膀胱癌	[14]
	has_circ_0000204	下调	miR-191	KLF6	肝癌	[15]
CKI	circ-ZKSCAN1	下调	miR-1178-3p	P21	膀胱癌	[16]
	circRNA BCRC-3	下调	miR-182-5p	P27	膀胱癌	[17]
CDK	circ-Foxo3	上调	-	P21/CDK2	乳腺癌	[18]
	circ-Ccnb1	下调	-	cyclin B1/CDK1	乳腺癌	[19]
EMT相关蛋白
EMT-TF	circPRMT5	上调	miR-30c	Snail	尿道上皮癌	[20,21]
	circNUP214	上调	miR-145	ZEB2	甲状腺乳头状癌	[22]
	circ-10720	上调	miR-490-5p	Twist1	肝细胞癌	[23]
	cirs-7	上调	miR-7	KLF4	食管鳞状细胞癌	[24]
	circNHSL1	上调	miR-1306-3p	Vimentin	胃癌	[25]
细胞黏附分子与骨架蛋白	circAMOTL1L	下调	miR-193a-5p	Pcdha8	前列腺癌	[25]
	circMTO1	上调	miR-221	N-CAD	膀胱癌	[26]
	circPTK2	下调	miR-429/miR-200b-3p	TIF1γ	非小细胞肺癌	[34]
相关信号通路
TGF-β/Smad	circRIP2	上调	miR-1305	TGF-β2	膀胱癌	[28]
Wnt/β-catenin	circMYO10	上调	miR-370-3p	RUVBL1	骨肉瘤	[29]
Notch	circNFIX	上调	miR-34a-5p	Notch1	神经胶质瘤	[30]
PI3K/Akt/mTOR	circNRIP1	上调	miR-149-5p	AKT1 / mTOR	胃癌	[31]
NF-κB	circRNA-000911	上调	miR-449a	Notch1	乳腺癌	[32]

Role of circular RNA in tumor proliferation and metastasis

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 36

Related Articles 15

Recommended Articles

Metrics

[1]	ZHOU Yunlan, SHEN Lisong. Clinical application and challenges of liquid biopsy biomarkers in non-small cell lung cancer [J]. Laboratory Medicine, 2023, 38(9): 807-811.
[2]	PENG Wei, LI Yungai, XU Jing, LIU Hua, YANG Cuixia, SHEN Yunyue. Serum inflammatory factors combined with PSA and f-PSA in the auxiliary diagnosis of prostate cancer [J]. Laboratory Medicine, 2023, 38(9): 849-854.
[3]	DING Xiaoyuan, DAI Jinsheng, JIAO Ronghong, MA Suli, ZHU Haifeng, WU Mengya, CHE Yanran, ZHANG Lei. Influence of obesity/overweight on inflammatory factors of Th1/Th2 and Th17/Treg in children with asthma attacks [J]. Laboratory Medicine, 2023, 38(8): 748-752.
[4]	ZHAO Jing, WANG Pei, LU Dandan, QI Dandan, LI Xuan. Expression levels of serum miR-4443 and TRAF4 in patients with hemorrhagic stroke [J]. Laboratory Medicine, 2023, 38(5): 413-418.
[5]	GAO Feng. Clinical application of novel tumor biomarkers：prospects and challenges [J]. Laboratory Medicine, 2023, 38(4): 303-306.
[6]	SONG Shiwei, LI Jingwu, LIN Tao, LIU Zeyu, WANG Zhiqiang, SUN Weidong. Relationship between GPNMB and non-small cell lung cancer immune infiltration and prognosis [J]. Laboratory Medicine, 2023, 38(4): 347-351.
[7]	WU Jiong, HU Jiahua, SHI Meifang, LIU Tao, DAI Jie, LU Xinyi, ZOU Zheng. Research progress of biomarkers of prostate cancer [J]. Laboratory Medicine, 2023, 38(2): 190-195.
[8]	QIAN Linyu, LIANG Weifang, TANG Sichen. Determination and clinical significance of NLRP3，CTRP6 and IL-1β in patients with gestational diabetes mellitus [J]. Laboratory Medicine, 2023, 38(10): 936-940.
[9]	SHANG Zhenjun, WEI Wei, LIU Ruihan. Effect of inhibiting PTBP1 on the proliferation and invasiveness of choroidal melanoma cells [J]. Laboratory Medicine, 2023, 38(1): 51-55.
[10]	WU Yating, LI Zhuolin, LEI Yan, JIA Ruxue, ZHANG Shenghang, WANG Shuiliang. Research progress of miRNA in urine as a biomarker for common malignant tumors [J]. Laboratory Medicine, 2023, 38(1): 94-99.
[11]	KONG Yujie, WANG Chen, HE Bing. Research progress of N6-methyladenosine in biological function and detection technology [J]. Laboratory Medicine, 2022, 37(9): 872-876.
[12]	WANG Rui, LI Zhaoyan, ZHAO Aiguang. Application of circulating tumor DNA detection in the diagnosis and treatment of gastric cancer [J]. Laboratory Medicine, 2022, 37(9): 877-881.
[13]	LIU Xingqiang, NING Lifen, LI Lin, CHEN Zhongcheng. Correlation of lung cancer clinicopathological characteristics with FR⁺-CTC,ANXA2 and ProGRP [J]. Laboratory Medicine, 2022, 37(8): 735-740.
[14]	WEN Shuzhan, FU Zile, CHEN Shuying. Expression and bioinformatics analysis of hsa-miR-34a in tumors [J]. Laboratory Medicine, 2022, 37(7): 657-663.
[15]	GAO Feng. Research progress of new tumor molecular markers in the age of precision medicine：from accurate diagnosis to precision chemotherapy [J]. Laboratory Medicine, 2022, 37(4): 309-312.